Identification and validation of heterotypic cell-in-cell structure as an adverse prognostic predictor for young patients of resectable pancreatic ductal adenocarcinoma

Signal Transduct Target Ther. 2020 Oct 20;5(1):246. doi: 10.1038/s41392-020-00346-w.

¹ Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, 10 Tieyi Road, Beijing, 100038, China. hhongy1999@126.com.
² Laboratory of General Surgery, The First Affiliated Hospital, Sun Yat-Sen University, 58 Zhongshan 2nd Road, Guangzhou, 510080, China.
³ Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, 10 Tieyi Road, Beijing, 100038, China.
⁴ Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China.
⁵ Department of Gastroenterology, Beijing Tiantan Hospital of Capital Medical University, Beijing, 100070, China. cuipeilin@bjtth.org.
⁶ Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China. xnwang88@163.com.
⁷ Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China. sunq@bmi.ac.cn.

No abstract available

Publication types